Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MACROGENICS INC Logo
A biopharmaceutical company developing antibody-based therapeutics for cancer.
United States of America
MGNX
MADRIGAL PHARMACEUTICALS, INC. Logo
Biopharmaceutical company with the first FDA-approved treatment for the liver disease MASH.
United States of America
MDGL
Magle Chemoswed Holding AB Logo
A CDMO serving the pharma and medical device industries from development to manufacturing.
Sweden
MAGLE
MAIA Biotechnology, Inc. Logo
Clinical-stage immuno-oncology company developing telomere-targeting cancer therapies.
United States of America
MAIA
A molecular genetics diagnostics company developing tests for early cancer detection.
Germany
MYNZ
MANNKIND CORP Logo
Biopharmaceutical firm developing inhaled therapies for cardiometabolic/orphan lung diseases.
United States of America
MNKD
MARAVAI LIFESCIENCES HOLDINGS, INC. Logo
Life sciences company providing nucleic acid production and biologics safety testing.
United States of America
MRVI
Marinomed Biotech AG Logo
Develops treatments for viral infectious diseases and immunological disorders.
Austria
MARI
Marker Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing T cell-based immunotherapies.
United States of America
MRKR
Maze Therapeutics, Inc. Logo
Develops small molecule precision medicines based on insights from human genetics.
United States of America
MAZE

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.